Ovid Therapeutics Inc

Small-Cap Stocks Penny Stocks Biotech Stocks Healthcare Stocks

$2.69

+0.01 (+0.37%)

As of Jul 4, 10:39 PM ET ·

Analyst Consensus

Strong Buy

Analysts

High

Coverage

Buy 15 94%

Hold 1 6%

Sell 0 0%

Price Target

Analyst Price Target +1,425.7% upside

Low Target $30.97

Average Target $41.04

High Target $66.83

Current Price $2.69

Current
$2.69

Target
$41.04

$30.97 $41.04 avg $66.83

Scenario Analysis

Bear Case

$30.97

1,051.3%

Low target

Base Case

$41.04

+1,425.7%

Avg target

Bull Case

$66.83

+2,384.4%

High target

Risk/Reward

2.3x

Favorable

Price in Context

52-Week High

$3.11

-13.4% from high

52-Week Low

$0.32

+745.1% from low

Target vs 52W High

$41.04

+1,221.7% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	78%	$257.58	-1.3%
AMGN Amgen Inc	Hold	44	50%	$190.87	-49.0%
GILD Gilead Sciences Inc	Strong Buy	39	82%	$362.68	+176.3%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	40	83%	$438.34	-17.0%
REGN Regeneron Pharmaceuticals	Buy	38	71%	$76.80	-88.3%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	37	76%	$102.31	-67.3%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-39.7%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-48.8%